TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20516432

Group type: EXPERIMENTAL
Intervention: Trabectedin plus pegylated liposomal doxorubicin (PLD)
Number of subjects: 672

Group type: COMPARATOR
Intervention: PLD alone
Number of subjects: 672

Group type: EXPERIMENTAL
Intervention: Trabectedin plus PLD
Number of subjects: 672

Group type: EXPERIMENTAL
Intervention: Trabectedin plus PLD (platinum-sensitive patients)
Number of subjects: 672

Group type: COMPARATOR
Intervention: PLD alone (platinum-sensitive patients)
Number of subjects: 672
Study: 18936423

Group type: EXPERIMENTAL
Intervention: Prestroke physical activity in the top quartile
Number of subjects: 265

Group type: COMPARATOR
Intervention: Control group (lowest quartile of physical activity)
Number of subjects: 265
Study: 16082837

Group type: EXPERIMENTAL
Intervention: Infusion therapy including solutions of colloids and crystalloids (n=43)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: High molecular hydroxyethyl starch in addition to colloids and crystalloids
Number of subjects: 71
Study: 12584787

Group type: EXPERIMENTAL
Intervention: Folium Ginkgo extract (FGE) 15 mg/kg.d for 7-8 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (conventional treatment only)
Number of subjects: 30
Study: 10721681

Group type: EXPERIMENTAL
Intervention: Citalopram (20 to 30 mg per day)
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: Citalopram (10 to 15 mg per day)
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: Citalopram (40 to 60 mg per day)
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: Clomipramine (60 to 90 mg per day)
Number of subjects: 475

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 475
Study: 8957146

Group type: EXPERIMENTAL
Intervention: Self-help attendance
Number of subjects: 519

Group type: COMPARATOR
Intervention: Non-attenders
Number of subjects: 519

Group type: COMPARATOR
Intervention: Non-participating attenders
Number of subjects: 519
Study: 1493669

Group type: EXPERIMENTAL
Intervention: Captopril (25 mg three times/day)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 4014126

Group type: EXPERIMENTAL
Intervention: Stepped Care (intensive treatment group)
Number of subjects: 2376

Group type: COMPARATOR
Intervention: Referred Care (usual medical care sources)
Number of subjects: 2376

Group type: EXPERIMENTAL
Intervention: Stepped Care
Number of subjects: 2376

Group type: COMPARATOR
Intervention: Referred Care
Number of subjects: 2376
Study: 31503241

Group type: EXPERIMENTAL
Intervention: Enhanced nutrition group
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 82
Study: 29676584

Group type: EXPERIMENTAL
Intervention: Current practice of ototoxicity management
Number of subjects: 134
Study: 27006427

Group type: EXPERIMENTAL
Intervention: Death certificate cause of death
Number of subjects: 1642
Study: 25479465

Group type: EXPERIMENTAL
Intervention: Web-based KIDSCREEN-52
Number of subjects: 923

Group type: COMPARATOR
Intervention: Paper KIDSCREEN-52
Number of subjects: 923
Study: 22089999

Group type: EXPERIMENTAL
Intervention: Group 2 (n = 16) performing ossicular and tympanic membrane reconstruction on Days 1, 7, 14, and 21
Number of subjects: 30

Group type: COMPARATOR
Intervention: Group 1 (n = 14) observing the procedure on Days 7 and 14
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Training with the tympanoplasty model
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Tremor indices and students' motivation
Number of subjects: 30
Study: 20842168

Group type: EXPERIMENTAL
Intervention: High-protein, high-fiber diet (HPHF)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Standard low-fat, high-carbohydrate diet
Number of subjects: 89
Study: 18180631

Group type: EXPERIMENTAL
Intervention: Half-cut Semmes-Weinstein monofilaments
Number of subjects: 36
Study: 16164529

Group type: EXPERIMENTAL
Intervention: Nurse-initiated education programme on osteoporosis prevention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no education programme)
Number of subjects: 0
Study: 14518528

Group type: EXPERIMENTAL
Intervention: Facilitative rehabilitation technique (task 2: support by a trainer to move the paretic hand with visual feedback)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Repetitive hand grasping (task 1: paretic hand at a rate of 0.5 Hz with eyes closed)
Number of subjects: 2
Study: 10552979

Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg), Amoxycillin (1 g), Metronidazole (400 mg) bd for 7 days (OAM)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg), Clarithromycin (250 mg), Metronidazole (400 mg) bd for 7 days (OCM)
Number of subjects: 30
Study: 8673196

Group type: EXPERIMENTAL
Intervention: Intervention group (experimental school)
Number of subjects: 80
Study: 29512972

Group type: EXPERIMENTAL
Intervention: Phyto-caffeine-containing shampoo
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control shampoo
Number of subjects: 100
Study: 29310119

Group type: EXPERIMENTAL
Intervention: Amoxicillin 250 mg b.i.d. (group B; experimental)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Amoxicillin 750 mg b.i.d. (group A; conventional)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Conventional regimen (group C; normal renal function)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Conventional regimen (group A; conventional)
Number of subjects: 37
Study: 27402282

Group type: EXPERIMENTAL
Intervention: Sensory relearning (n=52)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control (n=52)
Number of subjects: 104
Study: 24092834

Group type: EXPERIMENTAL
Intervention: Carbohydrate meal
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Protein meal
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Fat meal
Number of subjects: 8

Group type: COMPARATOR
Intervention: Low-calorie placebo
Number of subjects: 8
Study: 23342765

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBO2) combined with drugs
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (drugs only)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBO2)
Number of subjects: 68
Study: 19940079

Group type: EXPERIMENTAL
Intervention: Sodium nitrite (1 micromol/min) during hypoxia
Number of subjects: 18

Group type: COMPARATOR
Intervention: 0.9% saline during hypoxia
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Sodium nitrite (1 micromol/min) during normoxia
Number of subjects: 18
Study: 16996660

Group type: EXPERIMENTAL
Intervention: EN supplemented with a mixture of cysteine, threonine, serine and aspartate (AA patients)
Number of subjects: 12

Group type: COMPARATOR
Intervention: EN supplemented with alanine at isonitrogenous levels (Ala patients)
Number of subjects: 12
Study: 16286100

Group type: EXPERIMENTAL
Intervention: Tamsulosin (0.4 mg daily)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Hydration and tenoxicam (20 mg orally once daily)
Number of subjects: 67
Study: 12145221

Group type: EXPERIMENTAL
Intervention: Plant-based protein (PP)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Animal-based protein (AP)
Number of subjects: 17
Study: 9856921

Group type: EXPERIMENTAL
Intervention: Spontaneous recovery of sinus rhythm
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Intravenous procainamide
Number of subjects: 109

Group type: COMPARATOR
Intervention: DC shock
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Mode of cardioversion
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Normal left atrial size
Number of subjects: 109
Study: 7824108

Group type: EXPERIMENTAL
Intervention: 20% glucose infusion
Number of subjects: 9

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 9
Study: 2228650

Group type: EXPERIMENTAL
Intervention: 10 units of heparin in 1 ml sodium chloride solution
Number of subjects: 32

Group type: COMPARATOR
Intervention: 0.9% sodium chloride
Number of subjects: 32
Study: 204949

Group type: EXPERIMENTAL
Intervention: EEG sleep variables (REM latency, REM density, sleep efficiency, REM sleep percent, delta sleep percent)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EEG sleep variables (REM activity, intermittent nocturnal awakening)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tricyclic antidepressants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EEG sleep variables (REM latency)
Number of subjects: 0
Study: 30948522

Group type: EXPERIMENTAL
Intervention: Intermittent infusion of levobupivacaine [0.125%] bolus delivered every 2 hours (n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Continuous infusion of levobupivacaine [0.125%] (6 mL/hour) (n=20)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intermittent infusion of levobupivacaine [0.125%]
Number of subjects: 40

Group type: COMPARATOR
Intervention: Continuous infusion of levobupivacaine [0.125%]
Number of subjects: 40
Study: 27013239

Group type: EXPERIMENTAL
Intervention: Demand valve oxygen (DVO)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: O2ptimask
Number of subjects: 57

Group type: COMPARATOR
Intervention: Simple mask
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 26386766

Group type: EXPERIMENTAL
Intervention: RenalGuard group (hydration with normal saline solution controlled by the RenalGuard system and furosemide)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (normal saline solution)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: RenalGuard group
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 112
Study: 23822689

Group type: EXPERIMENTAL
Intervention: Low glycemic index diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: High glycemic index diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 0
Study: 21315352

Group type: EXPERIMENTAL
Intervention: Metoprolol CR/XL (25mg once daily)
Number of subjects: 341

Group type: COMPARATOR
Intervention: Fluvastatin (40 mg once daily)
Number of subjects: 341

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 341
Study: 19549752

Group type: EXPERIMENTAL
Intervention: high monounsaturated fatty acids (MUFA)/high glycemic index (GI)
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: high MUFA/low GI
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: low fat (LF)/high GI
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: LF/low GI
Number of subjects: 720

Group type: COMPARATOR
Intervention: reference diet (high saturated fatty acids (SF)/high glycemic index (GI))
Number of subjects: 720
Study: 16620697

Group type: EXPERIMENTAL
Intervention: Intravascular ultrasound imaging at 1.4 +/- 0.6 months and 12.1 +/- 0.7 months after cardiac transplantation
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Change in cross-sectional area stenosis
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Total cross-sectional area stenosis of 20%
Number of subjects: 190
Study: 15567796

Group type: EXPERIMENTAL
Intervention: Ropivacaine 20 ml (group R, n=33)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Ropivacaine combined with fentanyl (group RF, n=32)
Number of subjects: 65
Study: 11046100

Group type: EXPERIMENTAL
Intervention: HOE 140 (bradykinin B(2) receptor antagonist)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Furosemide (0.5 mg/kg i.v.)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: HOE 140 + Furosemide
Number of subjects: 10

Group type: COMPARATOR
Intervention: Furosemide
Number of subjects: 10
Study: 9381993

Group type: EXPERIMENTAL
Intervention: gemfibrozil + niacin + cholestyramine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 100
Study: 8407392

Group type: EXPERIMENTAL
Intervention: Hyperfractionated radiotherapy at 75.6 Gy (1.26 Gy twice daily for 6 weeks)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Hyperfractionated radiotherapy at 75.6 Gy
Number of subjects: 39
Study: 2944668

Group type: EXPERIMENTAL
Intervention: Constant SC infusion of ICI 118630
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Monthly SC slow-release depot formulation of ICI 118630
Number of subjects: 17

Group type: COMPARATOR
Intervention: 250-microgram SC bolus of ICI 118630
Number of subjects: 17
Study: 31128948

Group type: EXPERIMENTAL
Intervention: Interval cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin
Number of subjects: 245

Group type: COMPARATOR
Intervention: Interval cytoreductive surgery without hyperthermic intraperitoneal chemotherapy (HIPEC)
Number of subjects: 245
Study: 29869333

Group type: EXPERIMENTAL
Intervention: MiYoga
Number of subjects: 42

Group type: COMPARATOR
Intervention: Waitlist comparison
Number of subjects: 42
Study: 26958932

Group type: EXPERIMENTAL
Intervention: TELE sessions (videoconferencing-based communication)
Number of subjects: 97
Study: 24041110

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 202

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 202
Study: 23740156

Group type: EXPERIMENTAL
Intervention: Whole-brain radiotherapy (WBRT) alone
Number of subjects: 514
Study: 20646472

Group type: EXPERIMENTAL
Intervention: Side-to-side esophagogastric anastomosis (SS group)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Conventional hand-sewn esophagogastrostomy (HS group)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Circular stapled esophagogastrostomy (CS group)
Number of subjects: 155
Study: 18379802

Group type: EXPERIMENTAL
Intervention: Bio-resorbable implant (Reunite osteosynthesis plate by Biomet Inc)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Metal implant
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both groups (bio-resorbable and metal implants)
Number of subjects: 32
Study: 16052388

Group type: EXPERIMENTAL
Intervention: Radiofrequency endovenous obliteration
Number of subjects: 28

Group type: COMPARATOR
Intervention: Stripping of the long saphenous vein
Number of subjects: 28
Study: 12145070

Group type: EXPERIMENTAL
Intervention: 0.5% Ropivacaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (Normal Saline)
Number of subjects: 40
Study: 10189654

Group type: EXPERIMENTAL
Intervention: Intramuscular morphine sulphate (0.15 mg.kg‐1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Codeine phosphate (1.5 mg.kg‐1)
Number of subjects: 40
Study: 7780255

Group type: EXPERIMENTAL
Intervention: Obese children
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 59
Study: 2265301

Group type: EXPERIMENTAL
Intervention: In-the-ear hearing aids
Number of subjects: 244

Group type: COMPARATOR
Intervention: Behind-the-ear hearing aids
Number of subjects: 244

Group type: COMPARATOR
Intervention: In-the-canal hearing aids
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Gender comparison (females vs males)
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Manipulative tasks
Number of subjects: 244
Study: 7320448

Group type: EXPERIMENTAL
Intervention: Domiciliary care by midwives
Number of subjects: 996

Group type: COMPARATOR
Intervention: Traditional care
Number of subjects: 996
Study: 31584939

Group type: EXPERIMENTAL
Intervention: Maternal nutrition intervention (nutrition counseling and micronutrient supplements)
Number of subjects: 1100

Group type: COMPARATOR
Intervention: Control (MNCH program alone)
Number of subjects: 1100
Study: 30946495

Group type: EXPERIMENTAL
Intervention: PISCES delivered face to face (F2F)
Number of subjects: 514

Group type: COMPARATOR
Intervention: PISCES delivered via videoconferencing (VC)
Number of subjects: 514

Group type: COMPARATOR
Intervention: Standard care with added friendly calls (attention control [AC] group)
Number of subjects: 514
Study: 28958502

Group type: EXPERIMENTAL
Intervention: Dacomitinib 45 mg/day
Number of subjects: 452

Group type: COMPARATOR
Intervention: Gefitinib 250 mg/day
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Dacomitinib
Number of subjects: 452

Group type: COMPARATOR
Intervention: Gefitinib
Number of subjects: 452
Study: 25499852

Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 0
Study: 23384077

Group type: EXPERIMENTAL
Intervention: Lower alcohol dose group (mean BAC 0.04%, N = 40)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Higher alcohol dose group (mean BAC 0.06%, N = 44)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control group (mean BAC 0.00%, N = 42)
Number of subjects: 126
Study: 21631539

Group type: EXPERIMENTAL
Intervention: Interdependent self-construal
Number of subjects: 0

Group type: COMPARATOR
Intervention: Independent self-construal
Number of subjects: 0
Study: 18056792

Group type: EXPERIMENTAL
Intervention: 20% Intralipid infusion [0.7 ml.kg(‐1).h(‐1) (1.54 g/kg)] for 11 h
Number of subjects: 14

Group type: COMPARATOR
Intervention: Isotonic saline infusion for 11 h (control)
Number of subjects: 14
Study: 17263277

Group type: EXPERIMENTAL
Intervention: Midazolam‐remifentanil group (group I)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Midazolam‐fentanyl group (group II)
Number of subjects: 35
Study: 12728159

Group type: EXPERIMENTAL
Intervention: Tiotropium 18 micro g once daily
Number of subjects: 1207

Group type: EXPERIMENTAL
Intervention: Salmeterol 50 micro g twice daily
Number of subjects: 1207

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1207

Group type: EXPERIMENTAL
Intervention: Tiotropium
Number of subjects: 1207

Group type: EXPERIMENTAL
Intervention: Salmeterol
Number of subjects: 1207
Study: 11590493

Group type: EXPERIMENTAL
Intervention: PI plus two nucleosides
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: PI plus one nucleoside
Number of subjects: 166

Group type: COMPARATOR
Intervention: Only PI
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Triple therapy (PI plus two nucleosides)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Dual therapy (PI plus one nucleoside)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Triple therapy
Number of subjects: 166
Study: 9305714

Group type: EXPERIMENTAL
Intervention: Chemotherapy alone (8 cycles)
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Chemotherapy (6 cycles) plus radiation therapy
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: MSKCC model (> or = 3 adverse factors)
Number of subjects: 344
Study: 8371918

Group type: EXPERIMENTAL
Intervention: Apraclonidine 0.5% (3 times daily)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Apraclonidine 0.25% (3 times daily)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Timolol 0.5% (twice daily)
Number of subjects: 69
Study: 3092660

Group type: EXPERIMENTAL
Intervention: enprostil 70 micrograms
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: enprostil 35 micrograms
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 30101648

Group type: EXPERIMENTAL
Intervention: Computer-based risk reduction program
Number of subjects: 136

Group type: COMPARATOR
Intervention: Educational program about campus resources (active control condition)
Number of subjects: 136
Study: 29914095

Group type: EXPERIMENTAL
Intervention: High dose (HD) of Ecologic® Barrier (1 × 10^10 CFU per day)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Low dose (LD) of Ecologic® Barrier (2.5 × 10^8 CFU per day)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 27893675

Group type: EXPERIMENTAL
Intervention: 250 mg TUDCA plus UDCA placebo
Number of subjects: 199

Group type: COMPARATOR
Intervention: 250 mg UDCA plus TUDCA placebo
Number of subjects: 199
Study: 24743663

Group type: EXPERIMENTAL
Intervention: Many Men, Many Voices (3MV) intervention
Number of subjects: 0
Study: 21993405

Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 12000

Group type: EXPERIMENTAL
Intervention: Contralateral breast cancer
Number of subjects: 12000

Group type: EXPERIMENTAL
Intervention: Head and neck cancer
Number of subjects: 12000

Group type: EXPERIMENTAL
Intervention: Male oesophageal cancer
Number of subjects: 12000

Group type: EXPERIMENTAL
Intervention: Dose response modelling
Number of subjects: 12000
Study: 20070758

Group type: EXPERIMENTAL
Intervention: Single ball-type mini-implants (Group I)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Mini-implants splinted with a prefabricated bar (Group II)
Number of subjects: 45
Study: 19000365

Group type: COMPARATOR
Intervention: MDI (Metered Dose Inhaler)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: VOL (Volumatic spacer)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: AERO (Aerochamber Plus spacer)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Comparison of VOL and AERO
Number of subjects: 13
Study: 16186088

Group type: EXPERIMENTAL
Intervention: Behavioral drug abuse therapies
Number of subjects: 162
Study: 12966284

Group type: EXPERIMENTAL
Intervention: Collective multidisciplinary information session 2 to 6 weeks before surgery
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual verbal information (Control)
Number of subjects: 100
Study: 10571351

Group type: EXPERIMENTAL
Intervention: Laser trabeculoplasty and topical betaxolol twice daily in eligible eyes
Number of subjects: 255

Group type: COMPARATOR
Intervention: No initial treatment with close follow-up
Number of subjects: 255
Study: 9339040

Group type: EXPERIMENTAL
Intervention: Scleral and corneal tunnel incisions (6.0‐mm W; 3.5‐ and 2.5‐mm L scleral tunnel; 4.1‐mm linear and 2.5‐mm L corneal tunnel)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group of nonoperated eyes
Number of subjects: 0
Study: 2643357

Group type: EXPERIMENTAL
Intervention: Behavioral treatment plus a fixed schedule of nicotine gum
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Behavioral treatment plus an ad lib schedule
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Education plus a fixed schedule
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Education plus an ad lib schedule
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Behavioral treatment
Number of subjects: 89

Group type: COMPARATOR
Intervention: Education
Number of subjects: 89
Study: 1259398

Group type: EXPERIMENTAL
Intervention: Oxolinic acid (1.5 g twice daily by mouth for 5 to 12 days)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Ampicillin (after patient was changed from oxolinic acid)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Amoxicillin (3 patients responded to this treatment)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Oxolinic acid
Number of subjects: 7
Study: 29739680

Group type: EXPERIMENTAL
Intervention: Potassium bicarbonate supplementation (90 mmol × d−1)
Number of subjects: 0
Study: 28372647

Group type: EXPERIMENTAL
Intervention: Landiolol (5μg/kg/min)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 40